Our third of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office.
This course is available to watch on-demand and receive credit for up to one year from the date of webinar release. There is no live Q&A with faculty associated for this program. Registrants will be notified as new webinars in the series are released.
3.0 credits available until June 24, 2021. View the Accreditation Statement/Credit tab for details.
Personalized Approach to Thyroid Disorders Part 2: Lectures
Included in this webinar:
Thyroid Disorders in Pregnancy (Tim Korevaar)
Hypothyroidism After Thyroidectomy and Autoimmune: Do We Treat It Differently?
Hyperthyroidism: Personalized Therapeutic Options According to Etiology and Patient Preference
Initial Approach to Low Risk Thyroid Cancer
Approach to Advanced Thyroid Cancer
Upon completion of this educational activity, learners will be able to:
Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/.
Who Should Attend
American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).
Tim Korevaar, MD, PhD is a postdoctoral fellow at Erasmus University Medical Center in the Netherlands. After a research internship at the Oxford Center for Diabetes, Endocrinology and Metabolism, Dr. Korevaar obtained his MD at the Erasmus University Medical Center. He obtained a PhD at the Erasmus University Medical Center, Academic Center for Thyroid Diseases focusing on ‘thyroid hormone availability during pregnancy and early life: determinants, interpretation and consequences’ (cum laude). His main interest is to translate thyroid physiological aspects into clinically relevant epidemiological studies. His focus has particularly been on determinants of gestational thyroid function (including hCG and endocrine disrupting chemicals) and the risk of adverse pregnancy and child outcomes (including preterm birth and offspring neurocognition). Dr. Korevaar is the recipient of the British Thyroid Award (2014), ECE Young Investigator Award (2016), the Early Career Clinical Lectureship Award (SfE, 2016) and the Early Career Award of the Royal Dutch Academy of Arts and Sciences (2020). He has authored more than 80 peer-reviewed manuscripts and is coordinator of the Consortium on Thyroid and Pregnancy.
Douglas Forrest, PhD is a Senior Investigator at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. He was previously an Associate Professor of Human Genetics at Mount Sinai School of Medicine. He received his PhD from Glasgow University. He has dedicated most of his career to research into the developmental and neurodevelopmental functions of thyroid hormone. His interests include the role of thyroid hormone receptors and deiodination in thyroid hormone action. He is a recipient of the Merck Prize of the European Thyroid Association and the Van Meter Award of the ATA. He is an Associate Editor of Endocrinology. He has served on several committees of the ATA including the committee for Trainee and Career Advancement and is a Board member of the American Thyroid Association.
Anne R. Cappola, MD, ScM is a Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism, Director of Clinical Research in the Department of Medicine, and Director of the Center for Human Phenomic Science at the Perelman School of Medicine at the University of Pennsylvania. Dr. Cappola directs an NIH-funded research program on the hormonal alterations that occur with aging and the clinical impact of these changes, including the clinical impact of subclinical thyroid dysfunction in older individuals. Dr. Cappola is a highly productive investigator who has published over 100 research publications. Dr. Cappola is an elected member of the American Society for Clinical Investigation, the American Association of Physicians, and the Interurban Clinical Club and an Associate Editor for JAMA. She has received the Thyroid Clinical Research Mentor Award from the Endocrine Society and the American Thyroid Association’s Van Meter Award.
Rebecca S. Sippel, MD, FACS is Professor of Surgery, Chief of the Division of Endocrine Surgery, and Vice Chair of Academic Affairs and Professional Development at the University of Wisconsin. She is a nationally recognized leader in the field of endocrine surgery. She is currently serving as the program director for the Endocrine Surgery Fellowship at the University of Wisconsin. She is past Secretary of the American Association of Endocrine Surgeons and past President of Association for Academic Surgery. She has a highly productive clinical research program focusing on the diagnosis and management of patients with endocrine disorders and the outcomes of patients after surgery. She is currently PI on an R01 funded randomized controlled trial examining the utility of prophylactic central neck dissection for patients with clinically node negative thyroid cancer.
Cari Meinhold Kitahara, PhD, MS is an Investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, National Institutes of Health. She received an MHS and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Kitahara’s research focuses on the etiology of thyroid cancer and on the potential cancer risks associated with occupational and medical radiation exposure. She is Principal Investigator of the U.S. Radiologic Technologists cohort study and the Hyperthyroid Follow-Up Study (an extension of the original Cooperative Thyrotoxicosis Therapy Follow-up Study assembled in the 1960s). She is the 2019 recipient of the Van Meter Award from the American Thyroid Association and serves on the editorial board of Thyroid. She has authored over 120 peer-reviewed manuscripts.
Sarah C. Oltmann, MD, FACS attended Baylor University, graduating cum laude for her undergraduate degree. She went on to earn her medical degree at Texas Tech University Health Sciences Center, graduating Alpha Omega Alpha. She completed her general surgery residency at the University of Texas Southwestern Medical Center. She pursued endocrine surgery fellowship training at the University of Wisconsin in Madison, WI. After fellowship, she returned to the University of Texas Southwestern and Parkland Health and Hospital Systems, where she now is the Associate Program Chief of Quality and Best Practice for Parkland Health and Hospital Systems, Medical Director of the General Surgery Clinics, and Director of Endocrine Surgery. Her clinical practice focuses on the surgical management of diseases of the thyroid, parathyroid and adrenal glands. Research interests include management and clinical outcomes in endocrine surgery. She is a previous recipient of the ATA/ThyCa Research Grant for her work on cancer progression and therapeutic response in a mouse model of Medullary Thyroid Cancer. She is happily married, with two sons. She is an avid knitter.
Susan C. Pitt, MD, MPHS, FACS is an Assistant Professor of Surgery in the Division of Endocrine Surgery at the University of Wisconsin School of Medicine and Public Health. Her clinical practice includes patients with benign and malignant thyroid, parathyroid, and adrenal disease. Dr. Pitt’s NIH funded health services research focuses on reducing overtreatment of patients with thyroid cancer. Her research team investigates the role of emotions, like fear and anxiety, on treatment decision-making. They also utilize stakeholder engagement and have developed two decision support tools for patients with low-risk thyroid cancer. In addition to her medical degree from the Medical College of Wisconsin, Dr. Pitt has a master’s degree in Population Health Science from Washington University in St. Louis with a concentration in shared decision-making. She completed her residency at Washington University in St. Louis followed by an Endocrine Surgery fellowship at Brigham and Women’s Hospital. She holds national leadership positions in the Association of Academic Surgery and the Association of Women Surgeons and is an active member of the American Association of Endocrine Surgeons (AAES) and the American Thyroid Association. She is also a past recipient of the AAES Paul LoGerfo Research Award.
Reese W. Randle, MD, FACS is the Assistant Professor of Surgery at Wake Forest Baptist Medical Center. He obtained his medical degree from the University of Texas Health Science Center, Houston. As a board-certified general surgeon with additional fellowship training in endocrine surgery, he specializes in treating benign and malignant disease of the thyroid, parathyroid, and adrenal glands. Dr. Randle’s clinical research interests have largely focused on improving the quality and efficiency of endocrine surgery and improving the safety of surgical training. He has training in both quantitative and qualitative research methods and employ both in the study of thyroid cancer. He serves on the governing committee for the Collaborative Endocrine Surgery Quality Improvement Program through the American Association of Endocrine Surgeons (AAES) and is the alternate representative for the AAES to the Commission on Cancer.
Jennifer A. Sipos, MD, Program Co-Chair, is a Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University. She obtained her medical degree and received her Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally, including meetings for the Endocrine Society, American Thyroid Association, European Thyroid Association, American Association for Clinical Endocrinologists, Asia and Oceania Thyroid Association, Indian Endocrine Society, and International Society of Endocrinology. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules.
Patrick Ha, MD, FACS is a Professor and the Chief of Head and Neck Oncologic Surgery in the Department of Otolaryngology – Head and Neck Surgery (OHNS) at the University of California, San Francisco. He also holds the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professorship in Head and Neck Surgery. After graduating magna cum laude from Harvard University, he received his medical degree from The Johns Hopkins School of Medicine in Baltimore, Maryland. Dr. Ha completed his one-year internship at The Johns Hopkins Hospital, Baltimore, Maryland, and he also completed an otolaryngology residency from the same institution, followed by advanced training in head and neck surgery at The Johns Hopkins Hospital. In addition to his clinical and research work, he serves as the Medical Director for the UCSF Mission Bay Adult Services.
Masha J. Livhits, MD is an Assistant Professor of Surgery at the UCLA David Geffen School of Medicine. She attended college at the age of 12 through the highly competitive Early Entrance Program at California State University, Los Angeles. After completing her medical education at Washington University in St. Louis, she obtained her surgical training and Endocrine Surgery fellowship at UCLA. Dr. Livhits has published widely in the area of improving surgical outcomes and quality of care. She is dedicated to combining knowledge learned through research with her experience as a surgeon to deliver the best care to her patients. Her clinical and research interests include parathyroid disease, benign and malignant thyroid tumors, adrenal masses, and familial endocrine disorders. She helped to pioneer the new technique of single incision retroperitoneoscopic adrenalectomy in North America.
Mabel M. Ryder, MD is an Endocrinologist and Assistant Professor of Medicine at Mayo Clinic, Rochester. She completed her residency and endocrine fellowship at the University of Cincinnati College of Medicine. Dr. Ryder’s interests are endocrine cancers, thyroid disease and cancer, adrenal disorders and cancer, and the role of tumor microenvironment in facilitating thyroid cancer progressions. She is a member of the American Thyroid Association and International Thyroid Oncology Group.